Lichter Jay

CIK 00013763555 companiesKANSAS CITY, KS

SEC Profile

Transactions

Companies

Filings

CIK

0001376355

Recent Transactions

50 trades

Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$50.30/sh−104,892→ 2,684,380 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$44.75/sh−104,957→ 401,321 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$51.18/sh−2,995→ 506,278 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$51.18/sh−15,462→ 2,613,623 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$50.30/sh−102,732→ 2,629,085 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$44.75/sh−541,824→ 2,071,799 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$44.75/sh−553,219→ 2,115,373 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$50.30/sh−19,900→ 509,273 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-18$51.18/sh−15,788→ 2,668,592 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-17−348→ 9,142 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-17$13.22/sh+348→ 7,977 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-17$39.80/sh+237→ 8,214 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-17$50.02/sh−1,843→ 6,371 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-17−237→ 6,072 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-17$10.73/sh+348→ 7,629 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-17−836→ 21,940 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-17−348→ 9,142 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-17$17.00/sh+836→ 7,281 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$13.22/sh+2,070→ 15,995 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$17.00/sh+4,968→ 11,855 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$50.61/sh−5,710→ 529,173 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$50.61/sh−29,474→ 2,731,817 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$49.69/sh−11,657→ 534,883 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$10.73/sh+2,070→ 13,925 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$50.61/sh−30,094→ 2,789,272 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$50.80/sh−10,957→ 6,445 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-16−4,968→ 22,776 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-16−2,070→ 9,490 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-16−2,070→ 9,490 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$49.69/sh−61,445→ 2,819,366 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$49.69/sh−60,179→ 2,761,291 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-16$39.80/sh+1,407→ 17,402 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-10-16−1,407→ 6,309 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-30$10.73/sh+181→ 7,541 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-30−181→ 11,560 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-30−123→ 7,716 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-30$13.22/sh+181→ 7,722 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-30$39.80/sh+123→ 7,845 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-30$46.24/sh−958→ 6,887 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-30−181→ 11,560 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-30$17.00/sh+434→ 7,360 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-30−434→ 27,744 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-27−345→ 11,741 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-27−234→ 7,839 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$13.22/sh+345→ 8,518 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$39.80/sh+234→ 8,752 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$10.73/sh+345→ 8,173 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$47.74/sh−1,542→ 2,880,811 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$46.42/sh−45,894→ 2,822,981 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$17.00/sh+828→ 7,828 total

Companies

Recent Filings

Address

C/O ARATANA THERAPEUTICS, INC. 1901 OLATHE BOULEVARD

KANSAS CITY, KS, 66103

View on SEC.gov